This is a routine tax-withholding sale tied to RSU vesting, not a discretionary insider sell signal. No bearish read-through. Monitor for any unplanned open-market sales by insiders, but this filing alone does not warrant action.
RVMD drugs
RVMD drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 16 $195.92entry
- T+1 · 2mo ago +0.52%α −0.61% · $196.94
- T+5 · 8w ago −2.64%α −5.21% · $190.74
- T+20 · 5w ago −3.82%α −7.00% · $188.44
- T+43 · todayOpen
- T+60 · in 23d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Stephen Michael Kelsey, an officer of Revolution Medicines, Inc., filed a Form 144 indicating intent to sell 5,415 shares of common stock, with an estimated aggregate market value of approximately $1,103,414.55. The shares were acquired via RSU vesting on September 15, 2026, and the sale is intended to cover tax withholding obligations related to the vesting. This is a routine, small-scale sale relative to the officer's total holdings and the company's $44B market cap, with no bearish signal.
Key Facts
- Officer Stephen Michael Kelsey filed Form 144 to sell 5,415 shares of RVMD common stock.
- Estimated aggregate market value of the proposed sale is ~$1.1M.
- Shares were acquired via RSU vesting on September 15, 2026, and the sale is for tax withholding purposes.
- Kelsey still holds 92,531 shares of common stock as of September 11, 2026, valued at ~$18.7M.
- The sale represents a small fraction of his total holdings and is not a discretionary open-market sale.
Financial Impact
~$1.1M proposed sale, representing ~0.003% of RVMD's $44B market cap
Risk Factors
- No material risk identified from this filing; the sale is non-discretionary and small in scale.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001462808-26-000008 |
| Document: 0001462808-26-000008-index.html | 0001462808-26-000008 |
| Document: 0001462808-26-000008.txt | 0001462808-26-000008 |
Track record
44 reports on RVMD
7 of 10 bullish or bearish reports moved the stock their way by T+60. Best: +31.56% at T+60 after the Apr 21, 2026 report. 17 of 18 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $167.00 Now $166.87 −0.08% settles Feb 16
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $168.20 Now $166.87 −0.79% settles Feb 12
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $176.02 Now $166.87 −5.20% settles Feb 12
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $176.35 Now $166.87 −5.38% settles Feb 10
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Nov 4, 202612d ago 8-K Bullish 7/10 No price data
- Nov 4, 202612d ago Press Release Neutral 5/10 Entry $177.65 Now $166.87 −6.07% settles Feb 3
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $191.31 Now $166.87 −12.78% settles Jan 28
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $186.99 Now $166.87 −10.76% settles Jan 21
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $187.69 Now $166.87 −11.09% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers